[go: up one dir, main page]

Heller, 1985 - Google Patents

Controlled drug release from poly (ortho esters)—A surface eroding polymer

Heller, 1985

Document ID
6683037111571249470
Author
Heller J
Publication year
Publication venue
Journal of Controlled Release

External Links

Snippet

Poly (ortho esters) are a polymer system containing backbone linkages that are stable in base, hydrolyze at very slow rates at the physiological pH of 7.4, and become progressively more labile as the pH is lowered. A major rationale for developing this system was a need …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C08G63/08—Lactones or lactides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain

Similar Documents

Publication Publication Date Title
Heller Controlled drug release from poly (ortho esters)—A surface eroding polymer
Heller Development of poly (ortho esters): a historical overview
Schindler et al. Biodegradable polymers for sustained drug delivery
Pitt et al. The enzymatic surface erosion of aliphatic polyesters
Gouin et al. New polyanhydrides made from a bile acid dimer and sebacic acid: synthesis, characterization, and degradation
US4757128A (en) High molecular weight polyanhydride and preparation thereof
Heller et al. [31] Poly (ortho ester) biodegradable polymer systems
Chasin et al. Polyanhydrides as drug delivery systems
US4888176A (en) Controlled drug delivery high molecular weight polyanhydrides
Heller et al. Poly (ortho esters): synthesis, characterization, properties and uses
US4906474A (en) Bioerodible polyanhydrides for controlled drug delivery
Andreopoulos et al. Synthesis and properties
Leong et al. Bioerodible polyanhydrides as drug‐carrier matrices. I: Characterization, degradation, and release characteristics
Heller et al. Use of poly (ortho esters) for the controlled release of 5-fluorouracyl and a LHRH analogue
Heller Poly (ortho esters)
US4130639A (en) Absorbable pharmaceutical compositions based on isomorphic copolyoxalates
US3978203A (en) Sustained release of pharmaceuticals from polyester matrices
EP1659142A1 (en) Polyhydroxyalkanoate compositions having controlled degradation rates
Vert et al. Complexity of the hydrolytic degradation of aliphatic polyesters
JP2001517603A (en) Injectable biodegradable block copolymer gel for use in drug delivery
CY1556A (en) Novel polyesters,their preparation and pharmaceutical use
Heller Bioerodible systems
Dahiyat et al. Controlled release from poly (phosphoester) matrices
HU205711B (en) Process for producing pharmaceutical compositions with slow release, having polyester carrier containing alkylene oxide blocks, and for producing the carrier
US4186189A (en) Absorbable pharmaceutical compositions based on poly(alkylene oxalates)